Thymulin from the thymus dampens age-related inflammation
Louis links the shrinking thymus with age-related disease and highlights new research showing thymulin strongly dampens age-related inflammation and may be a 'youth factor' in young blood.
6 posts
Louis links the shrinking thymus with age-related disease and highlights new research showing thymulin strongly dampens age-related inflammation and may be a 'youth factor' in young blood.
Louis notes persistent lymphopenia is associated with higher mortality, possibly via thymus involution, and that absolute lymphocyte count is on a standard CBC. The quoted explanation links low ALC with worse outcomes in critically ill patients including those with heart failure.
Louis shares news of two Nature papers from Mass General Brigham using Framingham Heart Study data linking thymus health in adults to longer life, reduced disease risk and better cancer immunotherapy outcomes.
Louis shares a Nature article on biotech efforts to regrow the thymus, an immune organ that shrinks with age, hoping to treat diseases including heart disease and slow aging.
Louis shares news of two studies where AI measured thymus size and composition on routine CT scans to create a thymic health score. Higher scores were associated with lower mortality, and he notes calorie restriction and cardio exercise may slow thymic shrinkage.

Keck School of Medicine researchers received a 5-year, $3.2 million grant to study thymulin, a thymus hormone that restrains age-related chronic inflammation.